Cargando…
(18)F-Trifluoromethylated D-Cysteine as a Promising New PET Tracer for Glioma Imaging: Comparative Analysis With MRI and Histopathology in Orthotopic C6 Models
Comparing MRI and histopathology, this study aims to comprehensively explore the potential application of (18)F-trifluoromethylated D-cysteine (S-[(18)F]CF(3)-D-CYS) in evaluating glioma by using orthotopic C6 glioma models. Sprague–Dawley (SD) rats (n = 9) were implanted with C6 glioma cells. Tumor...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117348/ https://www.ncbi.nlm.nih.gov/pubmed/33996562 http://dx.doi.org/10.3389/fonc.2021.645162 |
_version_ | 1783691575316971520 |
---|---|
author | Ma, Hui Zhao, Jing Liu, Shaoyu Xie, Dingxiang Zhang, Zhanwen Nie, Dahong Wen, Fuhua Yang, Zhiyun Tang, Ganghua |
author_facet | Ma, Hui Zhao, Jing Liu, Shaoyu Xie, Dingxiang Zhang, Zhanwen Nie, Dahong Wen, Fuhua Yang, Zhiyun Tang, Ganghua |
author_sort | Ma, Hui |
collection | PubMed |
description | Comparing MRI and histopathology, this study aims to comprehensively explore the potential application of (18)F-trifluoromethylated D-cysteine (S-[(18)F]CF(3)-D-CYS) in evaluating glioma by using orthotopic C6 glioma models. Sprague–Dawley (SD) rats (n = 9) were implanted with C6 glioma cells. Tumor growth was monitored every week by multiparameter MRI [including dynamic contrast-enhanced MRI (DCE-MRI)], [(18)F]FDG, S-[(18)F]CF(3)-D-CYS, and [(18)F]FDOPA PET imaging. Repeated scans of the same rat with the two or three [(18)F]-labeled radiotracers were investigated. Initial regions of interest were manually delineated on T(2)WI and set on the same level of PET images, and tumor-to-normal brain uptake ratios (TNRs) were calculated to semiquantitatively assess the tracer accumulation in the tumor. The tumor volume in PET and histopathology was calculated. HE and Ki67 immunohistochemical staining were further performed. The correlations between the uptake of S-[(18)F]CF(3)-D-CYS and Ki67 were analyzed. Dynamic S-[(18)F]CF(3)-D-CYS PET imaging showed tumor uptake rapidly reached a peak, maintained plateau during 10–30 min after injection, then decreased slowly. Compared with [(18)F]FDG and [(18)F]FDOPA PET imaging, S-[(18)F]CF(3)-D-CYS PET demonstrated the highest TNRs (P < 0.05). There were no significant differences in the tumor volume measured on S-[(18)F]CF(3)-D-CYS PET or HE specimen. Furthermore, our results showed that the uptake of S-[(18)F]CF(3)-D-CYS was significantly positively correlated with tumor Ki67, and the poor accumulated S-[(18)F]CF(3)-D-CYS was consistent with tumor hemorrhage. There was no significant correlation between the S-[(18)F]CF(3)-D-CYS uptakes and the K(trans) values derived from DCE-MRI. In comparison with MRI and histopathology, S-[(18)F]CF(3)-D-CYS PET performs well in the diagnosis and evaluation of glioma. S-[(18)F]CF(3)-D-CYS PET may serve as a valuable tool in the clinical management of gliomas. |
format | Online Article Text |
id | pubmed-8117348 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81173482021-05-14 (18)F-Trifluoromethylated D-Cysteine as a Promising New PET Tracer for Glioma Imaging: Comparative Analysis With MRI and Histopathology in Orthotopic C6 Models Ma, Hui Zhao, Jing Liu, Shaoyu Xie, Dingxiang Zhang, Zhanwen Nie, Dahong Wen, Fuhua Yang, Zhiyun Tang, Ganghua Front Oncol Oncology Comparing MRI and histopathology, this study aims to comprehensively explore the potential application of (18)F-trifluoromethylated D-cysteine (S-[(18)F]CF(3)-D-CYS) in evaluating glioma by using orthotopic C6 glioma models. Sprague–Dawley (SD) rats (n = 9) were implanted with C6 glioma cells. Tumor growth was monitored every week by multiparameter MRI [including dynamic contrast-enhanced MRI (DCE-MRI)], [(18)F]FDG, S-[(18)F]CF(3)-D-CYS, and [(18)F]FDOPA PET imaging. Repeated scans of the same rat with the two or three [(18)F]-labeled radiotracers were investigated. Initial regions of interest were manually delineated on T(2)WI and set on the same level of PET images, and tumor-to-normal brain uptake ratios (TNRs) were calculated to semiquantitatively assess the tracer accumulation in the tumor. The tumor volume in PET and histopathology was calculated. HE and Ki67 immunohistochemical staining were further performed. The correlations between the uptake of S-[(18)F]CF(3)-D-CYS and Ki67 were analyzed. Dynamic S-[(18)F]CF(3)-D-CYS PET imaging showed tumor uptake rapidly reached a peak, maintained plateau during 10–30 min after injection, then decreased slowly. Compared with [(18)F]FDG and [(18)F]FDOPA PET imaging, S-[(18)F]CF(3)-D-CYS PET demonstrated the highest TNRs (P < 0.05). There were no significant differences in the tumor volume measured on S-[(18)F]CF(3)-D-CYS PET or HE specimen. Furthermore, our results showed that the uptake of S-[(18)F]CF(3)-D-CYS was significantly positively correlated with tumor Ki67, and the poor accumulated S-[(18)F]CF(3)-D-CYS was consistent with tumor hemorrhage. There was no significant correlation between the S-[(18)F]CF(3)-D-CYS uptakes and the K(trans) values derived from DCE-MRI. In comparison with MRI and histopathology, S-[(18)F]CF(3)-D-CYS PET performs well in the diagnosis and evaluation of glioma. S-[(18)F]CF(3)-D-CYS PET may serve as a valuable tool in the clinical management of gliomas. Frontiers Media S.A. 2021-04-29 /pmc/articles/PMC8117348/ /pubmed/33996562 http://dx.doi.org/10.3389/fonc.2021.645162 Text en Copyright © 2021 Ma, Zhao, Liu, Xie, Zhang, Nie, Wen, Yang and Tang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Ma, Hui Zhao, Jing Liu, Shaoyu Xie, Dingxiang Zhang, Zhanwen Nie, Dahong Wen, Fuhua Yang, Zhiyun Tang, Ganghua (18)F-Trifluoromethylated D-Cysteine as a Promising New PET Tracer for Glioma Imaging: Comparative Analysis With MRI and Histopathology in Orthotopic C6 Models |
title | (18)F-Trifluoromethylated D-Cysteine as a Promising New PET Tracer for Glioma Imaging: Comparative Analysis With MRI and Histopathology in Orthotopic C6 Models |
title_full | (18)F-Trifluoromethylated D-Cysteine as a Promising New PET Tracer for Glioma Imaging: Comparative Analysis With MRI and Histopathology in Orthotopic C6 Models |
title_fullStr | (18)F-Trifluoromethylated D-Cysteine as a Promising New PET Tracer for Glioma Imaging: Comparative Analysis With MRI and Histopathology in Orthotopic C6 Models |
title_full_unstemmed | (18)F-Trifluoromethylated D-Cysteine as a Promising New PET Tracer for Glioma Imaging: Comparative Analysis With MRI and Histopathology in Orthotopic C6 Models |
title_short | (18)F-Trifluoromethylated D-Cysteine as a Promising New PET Tracer for Glioma Imaging: Comparative Analysis With MRI and Histopathology in Orthotopic C6 Models |
title_sort | (18)f-trifluoromethylated d-cysteine as a promising new pet tracer for glioma imaging: comparative analysis with mri and histopathology in orthotopic c6 models |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117348/ https://www.ncbi.nlm.nih.gov/pubmed/33996562 http://dx.doi.org/10.3389/fonc.2021.645162 |
work_keys_str_mv | AT mahui 18ftrifluoromethylateddcysteineasapromisingnewpettracerforgliomaimagingcomparativeanalysiswithmriandhistopathologyinorthotopicc6models AT zhaojing 18ftrifluoromethylateddcysteineasapromisingnewpettracerforgliomaimagingcomparativeanalysiswithmriandhistopathologyinorthotopicc6models AT liushaoyu 18ftrifluoromethylateddcysteineasapromisingnewpettracerforgliomaimagingcomparativeanalysiswithmriandhistopathologyinorthotopicc6models AT xiedingxiang 18ftrifluoromethylateddcysteineasapromisingnewpettracerforgliomaimagingcomparativeanalysiswithmriandhistopathologyinorthotopicc6models AT zhangzhanwen 18ftrifluoromethylateddcysteineasapromisingnewpettracerforgliomaimagingcomparativeanalysiswithmriandhistopathologyinorthotopicc6models AT niedahong 18ftrifluoromethylateddcysteineasapromisingnewpettracerforgliomaimagingcomparativeanalysiswithmriandhistopathologyinorthotopicc6models AT wenfuhua 18ftrifluoromethylateddcysteineasapromisingnewpettracerforgliomaimagingcomparativeanalysiswithmriandhistopathologyinorthotopicc6models AT yangzhiyun 18ftrifluoromethylateddcysteineasapromisingnewpettracerforgliomaimagingcomparativeanalysiswithmriandhistopathologyinorthotopicc6models AT tangganghua 18ftrifluoromethylateddcysteineasapromisingnewpettracerforgliomaimagingcomparativeanalysiswithmriandhistopathologyinorthotopicc6models |